PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).Lauren C. Harshman, Mäneka Puligandla, Naomi B. Haas et al.|Journal of Clinical Oncology|2019Cited by 13